Tumor entity, UICC stage, current disease condition and cancer care setting were associated with CRP severity: The highest levels of CRP were found in patients with head and neck cancer, in patients with UICC stage IV, in patients with progressing disease and in patients who were recruited from inpatient acute care facilities. This evidence concerns the gene CRP and head and neck cancer.